OSSM-007

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameOSSM-007
Drug Alias Nameallogeneic interferon gamma-primed human bone marrow-derived mesenchymal stem cell therapy (Ossium Health)OSSM-007
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsGraft vs Host Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesOssium Health Inc
China Registration ClassN/A

Develop Information

Active CompaniesOssium Health Inc
Inactive CompaniesN/A
Active IndicationsGraft vs Host Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A